Moreover, chronic activation of IL-6/IL-6R signaling in adipose tissue was linked to the development of obesity-related metabolic disorders, such as insulin resistance and type 2 diabetes (123, 127). Here, IL6 is linked to obesity due to melanocortin 4 receptor deficiency.